Research Database

Does once-weekly semaglutide 2.4 mg reduce kidney function decline in people with overweight or obesity and established cardiovascular disease?

To assess whether oral semaglutide reduces kidney outcomes in adults with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney...

This study evaluated whether GLP-1 receptor agonists (semaglutide and tirzepatide) as secondary therapy slow kidney decline and improve...

This computational study investigates how mild injury-induced left-shifts in voltage-gated sodium channels (Nav-CLS), combined with functional Na/K pumps,...

This study investigates how metabolic limitations affecting ion gradients (sodium, calcium, potassium) in the brain alter neural activity and inter-regional...

This study investigates whether plasma sodium levels within the normal physiological range (136–143 mmol/L) correlate with cortical excitability, measured by...

This study investigated whether magnesium and potassium supplementation improves insomnia in patients with diabetes by measuring changes in sleep hormones and...

This study investigates how the electrogenic nature of the Na+/K+-ATPase pump (3 Na+ out, 2 K+ in) disrupts computational reliability in highly active spiking...

This study investigates whether deleting IP6K1, an enzyme that promotes degradation of the Na+/K+-ATPase (NKA), enhances NKA stability and suppresses neuronal...